Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants

Published:2023-05-02 Issue:1 Volume:26 Page:630-643
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Rodgers-Gray Barry S.¹^ORCID,Fullarton John R.¹^ORCID,Carbonell-Estrany Xavier²^ORCID,Keary Ian P.¹^ORCID,Tarride Jean-Éric³^ORCID,Paes Bosco A.⁴^ORCID

Affiliation:

1. Violicom Medical Limited, Aldermaston, UK

2. Neonatology Service, Hospital Clinic, Barcelona, Spain

3. Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Canada

4. Department of Pediatrics (Neonatal Division), McMaster University, Hamilton, Canada

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2202600

Reference78 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

2. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life

3. Association between respiratory syncytial virus hospitalization in infancy and childhood asthma

4. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

5. Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Birth characteristics as predictors of respiratory syncytial virus hospitalisation in newborns to optimise immunisation schedule;Acta Paediatrica;2024-01-24

2. Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants;Frontiers in Pediatrics;2024-01-12

3. Perspective: the potential of wastewater-based surveillance as an economically feasible game changer in reducing the global burden of pediatric respiratory syncytial virus infection;Frontiers in Public Health;2024-01-12

4. Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada;Frontiers in Public Health;2023-09-26

5. A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age;PLOS ONE;2023-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3